Zobrazeno 1 - 10
of 118
pro vyhledávání: '"David G. Grenache"'
Autor:
Caroline E Franks, Jieli Li, Magen Martinez, Christopher W Farnsworth, Patricia M Jones, David G Grenache, Qing H Meng, Ann M Gronowski
Publikováno v:
Clinical Chemistry. 69:606-614
Background The use of quantitative human chorionic gonadotropin (hCG) as a tumor marker is widely accepted despite lack of FDA-approval for oncology. Differences in iso- and glycoform recognition among hCG immunoassays is well established, exhibiting
Publikováno v:
Clinical Microbiology Newsletter. 44:33-40
Autor:
Lilian Okoye, James J. Wassenberg, Vincent A. Streva, Emanuele Montomoli, Claudia Zierold, Luca Pallavicini, Alessandro Torelli, Frank Blocki, David G Grenache, Tina Bunnell, Davide Zanin, Aaron Wagner, Arriel De La O, Ginevra Marzucchi, Edward Chu, Fabrizio Bonelli
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 59:1463-1467
Objectives COVID-19 has brought about tests from many manufacturers. While molecular and rapid antigen tests are targeted for early diagnosis, immunoassays have a larger role in epidemiological studies, understanding longitudinal immunity, and in vac
Publikováno v:
The Journal of Applied Laboratory Medicine. 6:1695-1697
Autor:
Mark Koenig, Amy Freeman, Kathleen Swanson, Richard VanNess, Eugene Sun, David G. Grenache, Michael Crossey, Craig Nelson, Lauretta Dozier
Publikováno v:
The American Journal of Managed Care. 27:60-65
Objectives To assess the impact of providing laboratory-generated near-real-time clinical insights for pregnant Medicaid members to managed care organization (MCO) care coordinators. Study design A prospective, nonrandomized feasibility study was con
Autor:
Catharine M. Sturgeon, David G Grenache, Sarah Johnson, Sam Rowlands, Fiona Gould, Ulf-Håkan Stenman, Stephen Andrew Butler
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 59:823-835
Home pregnancy tests (HPTs) available in Europe include accuracy and other performance claims listed on their packaging. Due to the lack of guidance on the standardisation of such products, it is often difficult to replicate these claims when tested
Publikováno v:
The Journal of Applied Laboratory Medicine
Introduction Neutralizing antibodies (NAbs) are capable of binding to a virus to render it incapable of infection. The ability of commercially available SARS-CoV-2 serological tests to detect NAbs has not been widely reported. We sought to correlate
Autor:
Jun Lu, David G. Grenache
Publikováno v:
The Journal of Applied Laboratory Medicine. 5:54-61
Background Pyruvate kinase (PK) deficiency is the most common cause of nonspherocytic hemolytic anemia owing to defective glycolysis. This study developed and validated an automated method to measure PK activity in red blood cells (RBCs). Methods PK
Autor:
Brandon S Walker, Richard E Nelson, Brian R Jackson, David G Grenache, Edward R Ashwood, Robert L Schmidt
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0131402 (2015)
Non-invasive prenatal testing (NIPT) is a relatively new technology for diagnosis of fetal aneuploidies. NIPT is more accurate than conventional maternal serum screening (MSS) but is also more costly. Contingent NIPT may provide a cost-effective alte
Externí odkaz:
https://doaj.org/article/347481f0e2cf4fb0897a1c77fd98c77c
Autor:
Fabrizio, Bonelli, Frank A, Blocki, Tina, Bunnell, Edward, Chu, Arriel, De La O, David G, Grenache, Ginevra, Marzucchi, Emanuele, Montomoli, Lilian, Okoye, Luca, Pallavicini, Vincent A, Streva, Alessandro, Torelli, Aaron, Wagner, Davide, Zanin, Claudia, Zierold, James J, Wassenberg
Publikováno v:
Clinical chemistry and laboratory medicineReferences. 59(8)
COVID-19 has brought about tests from many manufacturers. While molecular and rapid antigen tests are targeted for early diagnosis, immunoassays have a larger role in epidemiological studies, understanding longitudinal immunity, and in vaccine develo